Research Article

Development and Validation of a Discriminating In Vitro Dissolution Method for Oral Formulations Containing Satranidazole

Table 5

Linearity data.

Concentration (in mcg/mL)Absorbance

20.0822
40.1433
60.2175
80.2793
100.3398
150.5057
200.6301
250.7518
300.9204